Blood collection devices are medical tools that are used for collection of blood samples from veins or skin punctures for diagnostic and therapeutic purposes. These devices include needles, blood bags, vials, needle holders, vacuum tubes and syringes which help in convenient and safe collection of blood. They offer accurate blood sample collection that ensures integrity of sample for appropriate analysis and testing. The growing prevalence of chronic diseases such as cancer, cardiovascular diseases and diabetes has augmented the demand for accurate diagnostics which involves blood testing. This in turn is contributing towards the growth of the blood collection devices market.

The Global blood collection devices market is estimated to be valued at US$ 9,244.72 Mn in 2024 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the blood collection devices are Becton Dickinson and Co, Terumo Corp, Cardinal Health Inc, SARSTEDT AG & Co KG, Nipro Corp, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, Greiner Bio-One International GmbH, FL Medical SRL, and IntervacTechnology OU. These players are adopting strategies such as new product launches, geographical expansions and mergers & acquisitions to strengthen their foothold in the market.

The market presents significant opportunities in the form of increasing volume of elective surgeries and diagnostics testing procedures across emerging economies. Further, growing research activities in the field of personalized medicine and companion diagnostics will propel the demand.

Geographically, the key players are focusing on expanding their presence across Asia Pacific, Latin America, Middle East and Africa regions where availability of improved healthcare facilities, increasing healthcare expenditure and growing medical tourism are anticipated to boost the adoption of blood collection devices.

Market drivers:

- Growing geriatric population prone to chronic diseases fuels the demand

- Increasing healthcare expenditure across developing nations improves access to diagnostic services

Market restraints:

- High prices of advanced blood collection products limit their adoption in price sensitive markets

- Stringent regulatory approvals prolong market entry of novel devices

Segment Analysis

Needles and syringes sub segment dominates the blood collection devices market currently owing to wide use of these devices in drawing and transferring blood samples. Needles and syringes are used extensively in phlebotomy procedures across hospitals, clinics and diagnostic laboratories. They provide safe and sterile blood collection with minimal risk of contamination. Rising number of pathological tests conducted each year drives demand for needles and syringes used in blood drawing.

Blood collection tubes hold the second largest share in the market. Varied types of specially coated evacuated blood collection tubes are available for serum separation, plasma separation and whole blood collection based on downstream applications. Increasing diagnostic testing volumes for conditions like cancer, cardiac disorders etc. fuel consumption of blood collection tubes.

Global Analysis

North America commands the leading regional share in global blood collection devices market led by well established healthcare infrastructure and routine health checkups in countries like the United States. Growing elderly population susceptible to chronic diseases support market growth. Asia Pacific is the fastest expanding regional market propelled by rising healthcare expenditures, growing medical tourism and increasing awareness about early disease diagnosis in highly populated nations such as China and India. Launch of new advanced technologies that facilitate automated blood collection will further support lucrative prospects in Asia Pacific blood collection devices market through 2030.